C3AR1 and central nervous system cancer: Because of the high expression of C3AR1 in GBM, we tested the effect of the C3aR antagonist SB290157 in the extreme limiting dilution assay (ELDA) — a functional assay measuring the self-renewal capability of U3082MG glioma cells.